Filing Details

Accession Number:
0001225208-24-006325
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-05-23 16:12:12
Reporting Period:
2024-05-22
Accepted Time:
2024-05-23 16:12:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
885725 Boston Scientific Corp BSX Surgical & Medical Instruments & Apparatus (3841) 042695240
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1595612 J. Daniel Brennan 300 Boston Scientific Way
Marlborough MA 01752-1234
Evp And Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-05-22 16,863 $24.55 288,405 No 4 M Direct
Common Stock Acquisiton 2024-05-22 16,863 $17.26 305,268 No 4 M Direct
Common Stock Acquisiton 2024-05-22 15,642 $27.09 320,910 No 4 M Direct
Common Stock Acquisiton 2024-05-22 15,086 $16.31 335,996 No 4 M Direct
Common Stock Disposition 2024-05-22 64,454 $75.91 271,542 No 4 S Direct
Common Stock Disposition 2024-05-23 47,621 $75.11 223,921 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2024-05-22 15,642 $0.00 15,642 $27.09
Common Stock Stock Option (Right to Buy) Disposition 2024-05-22 16,863 $0.00 16,863 $17.26
Common Stock Stock Option (Right to Buy) Disposition 2024-05-22 15,086 $0.00 15,086 $16.31
Common Stock Stock Option (Right to Buy) Disposition 2024-05-22 16,863 $0.00 16,863 $24.55
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
46,927 2028-02-15 No 4 M Direct
16,865 2026-02-22 No 4 M Direct
15,087 2025-02-23 No 4 M Direct
55,600 2027-02-28 No 4 M Direct
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 21, 2024.
  2. Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $75.512 to $76.22, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  3. Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $74.86 to $75.48, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  4. Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 15, 2019, the first anniversary of the date of grant.
  5. Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant.
  6. Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant.
  7. Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant.